New Hampshire Trust trimmed its position in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 0.2% in the second quarter, according to its most recent filing with the SEC. The institutional investor owned 32,620 shares of the company’s stock after selling 69 shares during the period. Procter & Gamble comprises 1.1% of New Hampshire Trust’s investment portfolio, making the stock its 23rd biggest position. New Hampshire Trust’s holdings in Procter & Gamble were worth $5,197,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Nova Wealth Management Inc. purchased a new position in Procter & Gamble in the first quarter worth $26,000. Signature Resources Capital Management LLC raised its position in Procter & Gamble by 67.9% in the second quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after acquiring an additional 72 shares during the period. Quarry LP bought a new stake in Procter & Gamble in the first quarter worth about $33,000. Mid American Wealth Advisory Group Inc. bought a new stake in Procter & Gamble in the second quarter worth about $34,000. Finally, RMG Wealth Management LLC bought a new stake in Procter & Gamble in the second quarter worth about $37,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Insider Buying and Selling
In related news, CEO Jon R. Moeller sold 40,119 shares of the company’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $6,309,515.13. Following the sale, the chief executive officer directly owned 319,375 shares of the company’s stock, valued at $50,228,106.25. This represents a 11.16% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Marc S. Pritchard sold 9,849 shares of the company’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,548,952.23. Following the completion of the sale, the insider directly owned 182,422 shares in the company, valued at approximately $28,689,507.94. The trade was a 5.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 149,763 shares of company stock valued at $23,421,279 over the last quarter. 0.20% of the stock is currently owned by insiders.
Procter & Gamble Stock Performance
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings results on Friday, October 24th. The company reported $1.99 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.09. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company had revenue of $22.39 billion during the quarter, compared to analyst estimates of $22.23 billion. During the same quarter last year, the firm posted $1.93 earnings per share. The firm’s revenue was up 3.0% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, research analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Friday, October 24th will be paid a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend is Friday, October 24th. Procter & Gamble’s dividend payout ratio is presently 64.98%.
Wall Street Analysts Forecast Growth
Several brokerages have commented on PG. Berenberg Bank lifted their price objective on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a research report on Wednesday, September 17th. Raymond James Financial cut their target price on shares of Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating for the company in a research report on Monday, October 20th. Wells Fargo & Company cut their target price on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research report on Thursday, September 25th. Evercore ISI reiterated an “in-line” rating and set a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Finally, Barclays cut their target price on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 1st. Eleven equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $171.68.
Read Our Latest Analysis on PG
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also
- Five stocks we like better than Procter & Gamble
- P/E Ratio Calculation: How to Assess Stocks
- Tractor Supply Stock Looks Like a Buy-and-Hold Winner
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 3 Stocks Well Below 52-Week Highs Poised for a Q4 Rebound
- 5 Top Rated Dividend Stocks to Consider
- Big Banks Are Setting the Tone as Earnings Season Kicks Off
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
